Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1996 Dec;70(12):8318–8331. doi: 10.1128/jvi.70.12.8318-8331.1996

Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.

S Günther 1, N Piwon 1, A Iwanska 1, R Schilling 1, H Meisel 1, H Will 1
PMCID: PMC190919  PMID: 8970951

Abstract

Little is known about the functional significance of hepatitis B virus (HBV) sequence heterogeneity. Here we analyzed the type, frequency, and function of mutations in the core promoter/enhancer II region of HBV in immunosuppressed patients. The major HBV population in immunosuppressed patients with severe liver disease had deletions, insertions, and/or base changes in this region. Such mutations were not found in immunosuppressed patients with mild disease. Except for two mutations, all created a hepatocyte nuclear factor 1 (HNF1) binding site or a potential HNF3 binding site. Occasionally, known binding sites for C/EBP and HNF4 were additionally duplicated. Eleven mutated core promoter prototype sequences were functionally tested in the context of a wild-type genome by transfection in Huh7 cells. Despite the diversity of mutations tested, all decreased steady-state levels of pre-C mRNA drastically and increased those of the C mRNA/ pregenomic RNA. This correlated with reduced levels of secreted hepatitis B e antigen and increased intracellular levels of core and Pol proteins and replicative HBV DNA intermediates. The levels of secreted HBV DNA-containing particles were also increased although most of the mutations reduced the levels of pre-S/S mRNA and pre-S1, and pre-S2 proteins as well as secretion of hepatitis B surface antigen. These data reveal a novel class of HBV variants with HNF1 binding sites in the core promoter which are characterized by a defect in hepatitis B e antigen expression, enhanced replication, and altered protein levels, all probably mediated by altered transcription factor binding. The phenotype of these variants and their prevalence only in immunosuppressed patients with severe liver disease may indicate that they play a role in pathogenesis.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews N. C., Faller D. V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991 May 11;19(9):2499–2499. doi: 10.1093/nar/19.9.2499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arii M., Takada S., Koike K. Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene. 1992 Mar;7(3):397–403. [PubMed] [Google Scholar]
  3. Barlet V., Zarski J. P., Thelu M. A., Bichard P., Seigneurin J. M. Different prevalence of precore mutants in five members of a hepatitis-B-virus-infected family: evidence for a precore variant type in an asymptomatic anti-HBs patient. J Hepatol. 1994 Nov;21(5):797–805. doi: 10.1016/s0168-8278(94)80242-4. [DOI] [PubMed] [Google Scholar]
  4. Blum H. E., Zhang Z. S., Galun E., von Weizsäcker F., Garner B., Liang T. J., Wands J. R. Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol. 1992 Feb;66(2):1223–1227. doi: 10.1128/jvi.66.2.1223-1227.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chang H. K., Wang B. Y., Yuh C. H., Wei C. L., Ting L. P. A liver-specific nuclear factor interacts with the promoter region of the large surface protein gene of human hepatitis B virus. Mol Cell Biol. 1989 Nov;9(11):5189–5197. doi: 10.1128/mcb.9.11.5189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen I. H., Huang C. J., Ting L. P. Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus. J Virol. 1995 Jun;69(6):3647–3657. doi: 10.1128/jvi.69.6.3647-3657.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cullen B. R., Malim M. H. Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Methods Enzymol. 1992;216:362–368. doi: 10.1016/0076-6879(92)16033-g. [DOI] [PubMed] [Google Scholar]
  8. Fouillot N., Tlouzeau S., Rossignol J. M., Jean-Jean O. Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation. J Virol. 1993 Aug;67(8):4886–4895. doi: 10.1128/jvi.67.8.4886-4895.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fukuda R., Nguyen X. T., Ishimura N., Ishihara S., Chowdhury A., Kohge N., Akagi S., Watanabe M., Fukumoto S. X gene and precore region mutations in the hepatitis B virus genome in persons positive for antibody to hepatitis B e antigen: comparison between asymptomatic "healthy" carriers and patients with severe chronic active hepatitis. J Infect Dis. 1995 Nov;172(5):1191–1197. doi: 10.1093/infdis/172.5.1191. [DOI] [PubMed] [Google Scholar]
  10. Galibert F., Mandart E., Fitoussi F., Tiollais P., Charnay P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature. 1979 Oct 25;281(5733):646–650. doi: 10.1038/281646a0. [DOI] [PubMed] [Google Scholar]
  11. Gotoh K., Mima S., Uchida T., Shikata T., Yoshizawa K., Irie M., Mizui M. Nucleotide sequence of hepatitis B virus isolated from subjects without serum anti-hepatitis B core antibody. J Med Virol. 1995 Jul;46(3):201–206. doi: 10.1002/jmv.1890460306. [DOI] [PubMed] [Google Scholar]
  12. Guo W., Chen M., Yen T. S., Ou J. H. Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation. Mol Cell Biol. 1993 Jan;13(1):443–448. doi: 10.1128/mcb.13.1.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Günther S., Li B. C., Miska S., Krüger D. H., Meisel H., Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol. 1995 Sep;69(9):5437–5444. doi: 10.1128/jvi.69.9.5437-5444.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Günther S., Meisel H., Reip A., Miska S., Krüger D. H., Will H. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology. 1992 Mar;187(1):271–279. doi: 10.1016/0042-6822(92)90315-g. [DOI] [PubMed] [Google Scholar]
  15. Hasegawa K., Huang J., Rogers S. A., Blum H. E., Liang T. J. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol. 1994 Mar;68(3):1651–1659. doi: 10.1128/jvi.68.3.1651-1659.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Horikita M., Itoh S., Yamamoto K., Shibayama T., Tsuda F., Okamoto H. Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease. J Med Virol. 1994 Sep;44(1):96–103. doi: 10.1002/jmv.1890440118. [DOI] [PubMed] [Google Scholar]
  17. Johnson J. L., Raney A. K., McLachlan A. Characterization of a functional hepatocyte nuclear factor 3 binding site in the hepatitis B virus nucleocapsid promoter. Virology. 1995 Apr 1;208(1):147–158. doi: 10.1006/viro.1995.1138. [DOI] [PubMed] [Google Scholar]
  18. Kaneko M., Uchida T., Moriyama M., Arakawa Y., Shikata T., Gotoh K., Mima S. Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B. J Med Virol. 1995 Nov;47(3):204–208. doi: 10.1002/jmv.1890470304. [DOI] [PubMed] [Google Scholar]
  19. Kitamura T., Satoh K., Tominaga T., Taguchi F., Tajima A., Suzuki K., Aso Y., Yogo Y. Alteration in the JC polyomavirus genome is enhanced in immunosuppressed renal transplant patients. Virology. 1994 Jan;198(1):341–345. doi: 10.1006/viro.1994.1038. [DOI] [PubMed] [Google Scholar]
  20. Laskus T., Rakela J., Steers J. L., Wiesner R. H., Persing D. H. Precore and contiguous regions of hepatitis B virus in liver transplantation for end-stage hepatitis B. Gastroenterology. 1994 Dec;107(6):1774–1780. doi: 10.1016/0016-5085(94)90820-6. [DOI] [PubMed] [Google Scholar]
  21. Laskus T., Rakela J., Tong M. J., Nowicki M. J., Mosley J. W., Persing D. H. Naturally occurring hepatitis B virus mutants with deletions in the core promoter region. J Hepatol. 1994 Jun;20(6):837–841. doi: 10.1016/s0168-8278(05)80158-8. [DOI] [PubMed] [Google Scholar]
  22. Lau J. Y., Bain V. G., Smith H. M., Alexander G. J., Williams R. Modulation of hepatitis B viral antigen expression by immunosuppressive drugs in primary hepatocyte culture. Transplantation. 1992 Apr;53(4):894–898. doi: 10.1097/00007890-199204000-00034. [DOI] [PubMed] [Google Scholar]
  23. Lenhoff R. J., Summers J. Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes. J Virol. 1994 Sep;68(9):5706–5713. doi: 10.1128/jvi.68.9.5706-5713.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lilienbaum A., Crescenzo-Chaigne B., Sall A. A., Pillot J., Elfassi E. Binding of nuclear factors to functional domains of the duck hepatitis B virus enhancer. J Virol. 1993 Oct;67(10):6192–6200. doi: 10.1128/jvi.67.10.6192-6200.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lo W. Y., Ting L. P. Repression of enhancer II activity by a negative regulatory element in the hepatitis B virus genome. J Virol. 1994 Mar;68(3):1758–1764. doi: 10.1128/jvi.68.3.1758-1764.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. López-Cabrera M., Letovsky J., Hu K. Q., Siddiqui A. Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5069–5073. doi: 10.1073/pnas.87.13.5069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Moriyama K., Takada T., Tsutsumi Y., Fukada K., Ishibashi H., Niho Y., Maeda Y. Mutations in the transcriptional regulatory region of the precore and core/pregenome of a hepatitis B virus with defective HBeAg production. Fukuoka Igaku Zasshi. 1994 Nov;85(11):314–322. [PubMed] [Google Scholar]
  28. Okamoto H., Tsuda F., Akahane Y., Sugai Y., Yoshiba M., Moriyama K., Tanaka T., Miyakawa Y., Mayumi M. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol. 1994 Dec;68(12):8102–8110. doi: 10.1128/jvi.68.12.8102-8110.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Penna A., Chisari F. V., Bertoletti A., Missale G., Fowler P., Giuberti T., Fiaccadori F., Ferrari C. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med. 1991 Dec 1;174(6):1565–1570. doi: 10.1084/jem.174.6.1565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Preisler-Adams S., Schlayer H. J., Peters T., Hettler F., Gerok W., Rasenack J. Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch Virol. 1993;133(3-4):385–396. doi: 10.1007/BF01313777. [DOI] [PubMed] [Google Scholar]
  31. Raney A. K., Easton A. J., Milich D. R., McLachlan A. Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1. J Virol. 1991 Nov;65(11):5774–5781. doi: 10.1128/jvi.65.11.5774-5781.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rehermann B., Fowler P., Sidney J., Person J., Redeker A., Brown M., Moss B., Sette A., Chisari F. V. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med. 1995 Mar 1;181(3):1047–1058. doi: 10.1084/jem.181.3.1047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Repp R., Keller C., Borkhardt A., Csecke A., Schaefer S., Gerlich W. H., Lampert F. Detection of a hepatitis B virus variant with a truncated X gene and enhancer II. Arch Virol. 1992;125(1-4):299–304. doi: 10.1007/BF01309646. [DOI] [PubMed] [Google Scholar]
  34. Sato S., Suzuki K., Akahane Y., Akamatsu K., Akiyama K., Yunomura K., Tsuda F., Tanaka T., Okamoto H., Miyakawa Y. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med. 1995 Feb 15;122(4):241–248. doi: 10.7326/0003-4819-122-4-199502150-00001. [DOI] [PubMed] [Google Scholar]
  35. Su H., Yee J. K. Regulation of hepatitis B virus gene expression by its two enhancers. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2708–2712. doi: 10.1073/pnas.89.7.2708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Takahashi K., Aoyama K., Ohno N., Iwata K., Akahane Y., Baba K., Yoshizawa H., Mishiro S. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol. 1995 Dec;76(Pt 12):3159–3164. doi: 10.1099/0022-1317-76-12-3159. [DOI] [PubMed] [Google Scholar]
  37. Uchida T., Shimojima M., Gotoh K., Shikata T., Tanaka E., Kiyosawa K. "Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol Immunol. 1994;38(4):281–285. doi: 10.1111/j.1348-0421.1994.tb01777.x. [DOI] [PubMed] [Google Scholar]
  38. Wang Y., Chen P., Wu X., Sun A. L., Wang H., Zhu Y. A., Li Z. P. A new enhancer element, ENII, identified in the X gene of hepatitis B virus. J Virol. 1990 Aug;64(8):3977–3981. doi: 10.1128/jvi.64.8.3977-3981.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Weimer T., Salfeld J., Will H. Expression of the hepatitis B virus core gene in vitro and in vivo. J Virol. 1987 Oct;61(10):3109–3113. doi: 10.1128/jvi.61.10.3109-3113.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Will H., Cattaneo R., Darai G., Deinhardt F., Schellekens H., Schaller H. Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A. 1985 Feb;82(3):891–895. doi: 10.1073/pnas.82.3.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Will H., Reiser W., Weimer T., Pfaff E., Büscher M., Sprengel R., Cattaneo R., Schaller H. Replication strategy of human hepatitis B virus. J Virol. 1987 Mar;61(3):904–911. doi: 10.1128/jvi.61.3.904-911.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Yaginuma K., Koike K. Identification of a promoter region for 3.6-kilobase mRNA of hepatitis B virus and specific cellular binding protein. J Virol. 1989 Jul;63(7):2914–2920. doi: 10.1128/jvi.63.7.2914-2920.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Yaginuma K., Shirakata Y., Kobayashi M., Koike K. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci U S A. 1987 May;84(9):2678–2682. doi: 10.1073/pnas.84.9.2678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yee J. K. A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science. 1989 Nov 3;246(4930):658–661. doi: 10.1126/science.2554495. [DOI] [PubMed] [Google Scholar]
  45. Yogo Y., Kitamura T., Sugimoto C., Hara K., Iida T., Taguchi F., Tajima A., Kawabe K., Aso Y. Sequence rearrangement in JC virus DNAs molecularly cloned from immunosuppressed renal transplant patients. J Virol. 1991 May;65(5):2422–2428. doi: 10.1128/jvi.65.5.2422-2428.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yuh C. H., Chang Y. L., Ting L. P. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol. 1992 Jul;66(7):4073–4084. doi: 10.1128/jvi.66.7.4073-4084.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Yuh C. H., Ting L. P. C/EBP-like proteins binding to the functional box-alpha and box-beta of the second enhancer of hepatitis B virus. Mol Cell Biol. 1991 Oct;11(10):5044–5052. doi: 10.1128/mcb.11.10.5044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Yuh C. H., Ting L. P. Differentiated liver cell specificity of the second enhancer of hepatitis B virus. J Virol. 1993 Jan;67(1):142–149. doi: 10.1128/jvi.67.1.142-149.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Yuh C. H., Ting L. P. The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function. J Virol. 1990 Sep;64(9):4281–4287. doi: 10.1128/jvi.64.9.4281-4287.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Zacharias D. A., Garamszegi N., Strehler E. E. Characterization of persistent artifacts resulting from RT-PCR of alternatively spliced mRNAs. Biotechniques. 1994 Oct;17(4):652–655. [PubMed] [Google Scholar]
  51. Zhang P., McLachlan A. Differentiation-specific transcriptional regulation of the hepatitis B virus nucleocapsid gene in human hepatoma cell lines. Virology. 1994 Jul;202(1):430–440. doi: 10.1006/viro.1994.1359. [DOI] [PubMed] [Google Scholar]
  52. Zhang P., Raney A. K., McLachlan A. Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter. J Virol. 1993 Mar;67(3):1472–1481. doi: 10.1128/jvi.67.3.1472-1481.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zhou D. X., Yen T. S. Differential regulation of the hepatitis B virus surface gene promoters by a second viral enhancer. J Biol Chem. 1990 Dec 5;265(34):20731–20734. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES